Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Application
2.3.2 Market Size By Ownership
2.3.2 Market Size By Center Type
2.3.2 Market Size By Services
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Screening Uptake and Eligibility Trends (2024)
4.1.1 Percentage of eligible individuals undergoing screening, by region
4.1.2 Growth in screening adherence among high-risk populations (age, smoking history)
4.1.3 Expansion in the screening pool due to updated clinical guidelines (USPSTF, NCCN, etc.)
4.2 Modality Usage Distribution (2024)
4.2.1 Market share of screening modalities (LDCT, Chest X-ray, Sputum Cytology, Biomarker-based, Others)
4.2.2 Annual growth rates for advanced and emerging screening tests
4.2.3 Diagnostic performance metrics (sensitivity/specificity) by test modality
4.3 Lung Cancer Detection Rates by Stage and Modality (2024)
4.3.1 Early vs. late-stage detection trends by screening method
4.3.2 Comparative NSCLC and SCLC detection statistics
4.3.3 Screening effectiveness in reducing mortality and disease burden
4.4 Regional Screening Program Penetration (2020–2032)
4.4.1 Government-led lung cancer screening programs and coverage
4.4.2 Role of NGOs, public-private partnerships, and rural outreach
4.4.3 Volume of mobile screening units and community-based deployments
4.5 Economic Burden Avoidance and Cost Savings through Screening (2024)
4.5.1 Cost savings from early diagnosis and treatment deferral
4.5.2 Comparative cost-per-diagnosis by test type
4.5.3 Cost-effectiveness of national and regional screening strategies
4.6 AI & Software Integration Trends (2024–2030)
4.6.1 Penetration of AI-assisted interpretation in LDCT and radiology workflows
4.6.2 Impact of AI tools on false positives/negatives and workflow efficiency
4.6.3 Regional reimbursement landscape for AI-enabled screening tools
5. Lung Cancer Screening Market Segmental Analysis & Forecast, Type of Test / Modality, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Low-Dose Computed Tomography (LDCT)
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Chest X-ray
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Sputum Cytology
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Biomarker-based Tests
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Others (e.g., PET scans, MRI)
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
6. Lung Cancer Screening Market Segmental Analysis & Forecast, By Cancer Type, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Non-Small Cell Lung Cancer (NSCLC)
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Small Cell Lung Cancer (SCLC)
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
7. Lung Cancer Screening Market Segmental Analysis & Forecast, By Age Group, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 40–49 years
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 50–59 years
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 60–69 years
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
7.5 70+ years
7.5.1 Key Trends
7.5.2 Market Size & Forecast, 2021 – 2032
8. Lung Cancer Screening Market Segmental Analysis & Forecast, By End User, 2021 – 2032, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Diagnostic Centers
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Cancer Research Institutes
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
8.5 Ambulatory Surgical Centers (ASCs)
8.5.1 Key Trends
8.5.2 Market Size & Forecast, 2021 – 2032
8.6 Others (mobile screening units, NGOs, etc.)
8.6.1 Key Trends
8.6.2 Market Size & Forecast, 2021 – 2032
9. Lung Cancer Screening Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.2.3 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.2.4 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.2.5 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.2.6 Lung Cancer Screening Market Size & Forecast, By Country, 2021 – 2032
9.2.6.1 USA
9.2.6.1.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.2.6.1.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.2.6.1.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.2.6.1.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.2.6.2 Canada
9.2.6.2.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.2.6.2.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.2.6.2.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.2.6.2.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3 Europe
9.3.1 Key Trends
9.3.2 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.3 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.4 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.5 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6 Lung Cancer Screening Market Size & Forecast, By Country, 2021 – 2032
9.3.6.1 Germany
9.3.6.1.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.1.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.1.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.1.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.2 UK
9.3.6.2.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.2.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.2.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.2.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.3 France
9.3.6.3.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.3.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.3.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.3.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.4 Italy
9.3.6.4.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.4.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.4.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.4.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.5 Spain
9.3.6.5.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.5.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.5.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.5.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.6 Russia
9.3.6.6.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.6.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.6.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.6.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.7 Poland
9.3.6.7.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.7.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.7.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.7.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.3.6.8 Rest of Europe
9.3.6.8.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.3.6.8.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.3.6.8.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.3.6.8.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.3 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.4 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.5 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6 Lung Cancer Screening Market Size & Forecast, By Country, 2021 – 2032
9.4.6.1 China
9.4.6.1.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.1.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.1.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.1.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.2 India
9.4.6.2.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.2.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.2.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.2.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.3 Japan
9.4.6.3.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.3.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.3.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.3.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.4 South Korea
9.4.6.4.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.4.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.4.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.4.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.5 Australia
9.4.6.5.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.5.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.5.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.5.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.6 ASEAN Countries
9.4.6.6.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.6.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.6.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.6.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.4.6.7 Rest of Asia-Pacific
9.4.6.7.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.4.6.7.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.4.6.7.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.4.6.7.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5 Latin America
9.5.1 Key Trends
9.5.2 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.3 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.4 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.5 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5.6 Lung Cancer Screening Market Size & Forecast, By Country, 2021 – 2032
9.5.6.1 Brazil
9.5.6.1.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.6.1.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.6.1.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.6.1.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5.6.2 Argentina
9.5.6.2.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.6.2.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.6.2.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.6.2.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5.6.3 Mexico
9.5.6.3.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.6.3.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.6.3.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.6.3.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5.6.4 Colombia
9.5.6.4.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.6.4.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.6.4.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.6.4.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.5.6.5 Rest of Latin America
9.5.6.5.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.5.6.5.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.5.6.5.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.5.6.5.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.3 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.4 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.5 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6 Lung Cancer Screening Market Size & Forecast, By Country, 2021 – 2032
9.6.6.1 UAE
9.6.6.1.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.1.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.1.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.1.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6.2 Saudi Arabia
9.6.6.2.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.2.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.2.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.2.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6.3 Qatar
9.6.6.3.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.3.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.3.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.3.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6.4 Egypt
9.6.6.4.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.4.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.4.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.4.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6.5 South Africa
9.6.6.5.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.5.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.5.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.5.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
9.6.6.6 Rest of Middle East & Africa
9.6.6.6.1 Lung Cancer Screening Market Size & Forecast, By Type of Test / Modality, 2021 – 2032
9.6.6.6.2 Lung Cancer Screening Market Size & Forecast, By Cancer Type, 2021 – 2032
9.6.6.6.3 Lung Cancer Screening Market Size & Forecast, By Age Group, 2021 – 2032
9.6.6.6.4 Lung Cancer Screening Market Size & Forecast, By End User, 2021 – 2032
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6 Key Company Profiles
10.6.1 GE HealthCare
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Siemens Healthineers
10.6.2.1 Company Overview & Snapshot
10.6.2.2 Product/Service Portfolio
10.6.2.3 Key Company Financials
10.6.2.4 SWOT Analysis
10.6.3 Philips Healthcare
10.6.3.1 Company Overview & Snapshot
10.6.3.2 Product/Service Portfolio
10.6.3.3 Key Company Financials
10.6.3.4 SWOT Analysis
10.6.4 Canon Medical Systems Corporation
10.6.4.1 Company Overview & Snapshot
10.6.4.2 Product/Service Portfolio
10.6.4.3 Key Company Financials
10.6.4.4 SWOT Analysis
10.6.5 Fujifilm Holdings Corporation
10.6.5.1 Company Overview & Snapshot
10.6.5.2 Product/Service Portfolio
10.6.5.3 Key Company Financials
10.6.5.4 SWOT Analysis
10.6.6 Samsung Medison Co., Ltd.
10.6.6.1 Company Overview & Snapshot
10.6.6.2 Product/Service Portfolio
10.6.6.3 Key Company Financials
10.6.6.4 SWOT Analysis
10.6.7 Carestream Health
10.6.7.1 Company Overview & Snapshot
10.6.7.2 Product/Service Portfolio
10.6.7.3 Key Company Financials
10.6.7.4 SWOT Analysis
10.6.8 Shimadzu Corporation
10.6.8.1 Company Overview & Snapshot
10.6.8.2 Product/Service Portfolio
10.6.8.3 Key Company Financials
10.6.8.4 SWOT Analysis
10.6.9 Vuno Inc.
10.6.9.1 Company Overview & Snapshot
10.6.9.2 Product/Service Portfolio
10.6.9.3 Key Company Financials
10.6.9.4 SWOT Analysis
10.6.10 Zebra Medical Vision
10.6.10.1 Company Overview & Snapshot
10.6.10.2 Product/Service Portfolio
10.6.10.3 Key Company Financials
10.6.10.4 SWOT Analysis
10.6.11 Qure.ai
10.6.11.1 Company Overview & Snapshot
10.6.11.2 Product/Service Portfolio
10.6.11.3 Key Company Financials
10.6.11.4 SWOT Analysis
10.6.12 Aidoc
10.6.12.1 Company Overview & Snapshot
10.6.12.2 Product/Service Portfolio
10.6.12.3 Key Company Financials
10.6.12.4 SWOT Analysis
10.6.13 Riverain Technologies
10.6.13.1 Company Overview & Snapshot
10.6.13.2 Product/Service Portfolio
10.6.13.3 Key Company Financials
10.6.13.4 SWOT Analysis
10.6.14 Lunit Inc.
10.6.14.1 Company Overview & Snapshot
10.6.14.2 Product/Service Portfolio
10.6.14.3 Key Company Financials
10.6.14.4 SWOT Analysis
10.6.15 Roche Diagnostics
10.6.15.1 Company Overview & Snapshot
10.6.15.2 Product/Service Portfolio
10.6.15.3 Key Company Financials
10.6.15.4 SWOT Analysis
10.6.16 Illumina, Inc.
10.6.16.1 Company Overview & Snapshot
10.6.16.2 Product/Service Portfolio
10.6.16.3 Key Company Financials
10.6.16.4 SWOT Analysis
10.6.17 Guardant Health
10.6.17.1 Company Overview & Snapshot
10.6.17.2 Product/Service Portfolio
10.6.17.3 Key Company Financials
10.6.17.4 SWOT Analysis
10.6.18 Exact Sciences Corporation
10.6.18.1 Company Overview & Snapshot
10.6.18.2 Product/Service Portfolio
10.6.18.3 Key Company Financials
10.6.18.4 SWOT Analysis
10.6.19 Bio-Rad Laboratories
10.6.19.1 Company Overview & Snapshot
10.6.19.2 Product/Service Portfolio
10.6.19.3 Key Company Financials
10.6.19.4 SWOT Analysis
10.6.20 CT Screening International
10.6.20.1 Company Overview & Snapshot
10.6.20.2 Product/Service Portfolio
10.6.20.3 Key Company Financials
10.6.20.4 SWOT Analysis
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
